Company Filing History:
Years Active: 1998
Title: Innovations of Jakob M Bogenberger in Megakaryocyte Growth Factors
Introduction
Jakob M Bogenberger is a notable inventor based in Camarillo, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of proteins that stimulate megakaryocyte growth. With a total of 2 patents, his work has the potential to impact medical treatments related to platelet production.
Latest Patents
Bogenberger's latest patents include innovative discoveries in the realm of megakaryocyte growth and development factors (MGDFs). These novel proteins are designed to stimulate the growth of megakaryocytes, which are essential for the production of platelets. His patents detail methods for creating MGDF derivatives that are attached to water-soluble polymers, such as polyethylene glycol. This advancement not only enhances the biological activity of these proteins but also provides methods for their preparation and production through recombinant genetic engineering techniques.
Career Highlights
Jakob M Bogenberger is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen focuses on the development of therapeutic proteins that can significantly improve patient outcomes in conditions related to low platelet counts. His expertise in this area has positioned him as a key figure in the advancement of treatments that utilize MGDFs.
Collaborations
Bogenberger has collaborated with notable colleagues, including Timothy D Bartley and Robert A Bosselman. These partnerships have fostered a collaborative environment that enhances the innovation and development of new biotechnological solutions.
Conclusion
Jakob M Bogenberger's contributions to the field of megakaryocyte growth factors represent a significant advancement in biotechnology. His innovative patents and work at Amgen Inc. highlight the importance of research in developing effective treatments for medical conditions related to platelet production.